To ban or not to ban: direct-to-consumer advertising and human rights analysis

To ban or not to ban?

The past four years have seen a steady increase in the number of companies that offer direct-to-consumer (DTC) genetic testing services and in the number of such tests for genetic risk factors, including a wide range of diseases and other non-disease-related traits. These companies sell their tests outside the traditional healthcare setting and often do not involve healthcare professionals for ...

To ban or not to ban? - that is the question.

Vending machines in schools: to ban or not to ban?

hydrolysate, soy and conventional cow milk formulas on incidence of atopic disease in high risk infants. Annals of Allergy 1989; 63: 102–6. 4 Chandra R. Five-year follow-up of high risk infants with family history of allergy who were exclusively breastfed or fed partial whey hydrolysate, soy and conventional cow’s milk formulas. Journal of Pediatriatric Gastroenterology and Nutrition 1997; 24: ...

Animal growth promoters: to ban or not to ban? A risk assessment approach.

The use of antibiotics for animal growth promotion has been controversial because of the potential transfer of antibiotic resistance from animals to humans. Such transfer could have severe public health implications in that treatment failures could result. We have followed a risk assessment approach to evaluate policy options for the streptogramin-class of antibiotics: virginiamycin, an animal ...

Trade Agreements and Direct-to-Consumer Advertising of Pharmaceuticals

There is growing international concern about the risks posed by direct-to-consumer advertising (DTCA) of prescription pharmaceuticals, including via the internet. Recent trade agreements negotiated by the United States, however, incorporate provisions that may constrain national regulation of DTCA. Some provisions explicitly mention DTCA; others enable foreign investors to seek compensation if ...